Filing Details
- Accession Number:
- 0001223203-10-000260
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-07 16:30:38
- Reporting Period:
- 2010-09-03
- Filing Date:
- 2010-09-07
- Accepted Time:
- 2010-09-07 16:30:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1405197 | Talecris Biotherapeutics Holdings Corp. | V9SNS*IJ | Pharmaceutical Preparations (2834) | 202533768 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1260616 | J Thomas Lynch | 79 Tw Alexander Drive 4101 Research Commons Research Triangle Park NC 27709 | Sr. Vp, Corp. Compliance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-09-03 | 113,440 | $22.50 | 21,120 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2010.
- The number of shares reported includes restricted share units representing the right to receive 2,631 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
Billionaire Hedge Funds
